Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Bifidobacteria Market Report 2016

  • QYR679011
  • 119 Pages
  • September 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Bifidobacteria

Revenue, means the sales value of Bifidobacteria

This report studies sales (consumption) of Bifidobacteria in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Lallemand, Inc

Koninklijke DSM N.V

Cargill, Inc

Chr. Hansen Holding A/S

E.I. du Pont de Nemours and Company

Lesaffre Group

Novozymes

Advanced BioNutrition Corporation

Calpis Co., Ltd

Nebraska Cultures Inc

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Dry

Liquid

Type III

Split by applications, this report focuses on sales, market share and growth rate of Bifidobacteria in each application, can be divided into

Food

Drink

Application 3

Table of Contents

United States Bifidobacteria Market Report 2016

1 Bifidobacteria Overview

1.1 Product Overview and Scope of Bifidobacteria

1.2 Classification of Bifidobacteria

1.2.1 Dry

1.2.2 Liquid

1.2.3 Type III

1.3 Application of Bifidobacteria

1.3.1 Food

1.3.2 Drink

1.3.3 Application 3

1.4 USA Market Size Sales (Value) and Revenue (Volume) of Bifidobacteria (2011-2021)

1.4.1 USA Bifidobacteria Sales and Growth Rate (2011-2021)

1.4.2 USA Bifidobacteria Revenue and Growth Rate (2011-2021)

2 USA Bifidobacteria Competition by Manufacturers

2.1 USA Bifidobacteria Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Bifidobacteria Revenue and Share by Manufactures (2015 and 2016)

2.3 USA Bifidobacteria Average Price by Manufactures (2015 and 2016)

2.4 Bifidobacteria Market Competitive Situation and Trends

2.4.1 Bifidobacteria Market Concentration Rate

2.4.2 Bifidobacteria Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 USA Bifidobacteria Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 USA Bifidobacteria Sales and Market Share by Type (2011-2016)

3.2 USA Bifidobacteria Revenue and Market Share by Type (2011-2016)

3.3 USA Bifidobacteria Price by Type (2011-2016)

3.4 USA Bifidobacteria Sales Growth Rate by Type (2011-2016)

4 USA Bifidobacteria Sales (Volume) by Application (2011-2016)

4.1 USA Bifidobacteria Sales and Market Share by Application (2011-2016)

4.2 USA Bifidobacteria Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 USA Bifidobacteria Manufacturers Profiles/Analysis

5.1 Lallemand, Inc

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Bifidobacteria Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Lallemand, Inc Bifidobacteria Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Koninklijke DSM N.V

5.2.2 Bifidobacteria Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Koninklijke DSM N.V Bifidobacteria Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Cargill, Inc

5.3.2 Bifidobacteria Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Cargill, Inc Bifidobacteria Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Chr. Hansen Holding A/S

5.4.2 Bifidobacteria Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Chr. Hansen Holding A/S Bifidobacteria Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 E.I. du Pont de Nemours and Company

5.5.2 Bifidobacteria Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 E.I. du Pont de Nemours and Company Bifidobacteria Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Lesaffre Group

5.6.2 Bifidobacteria Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Lesaffre Group Bifidobacteria Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Novozymes

5.7.2 Bifidobacteria Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Novozymes Bifidobacteria Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Advanced BioNutrition Corporation

5.8.2 Bifidobacteria Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Advanced BioNutrition Corporation Bifidobacteria Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Calpis Co., Ltd

5.9.2 Bifidobacteria Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Calpis Co., Ltd Bifidobacteria Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Nebraska Cultures Inc

5.10.2 Bifidobacteria Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Nebraska Cultures Inc Bifidobacteria Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

6 Bifidobacteria Manufacturing Cost Analysis

6.1 Bifidobacteria Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Bifidobacteria

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Bifidobacteria Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Bifidobacteria Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 USA Bifidobacteria Market Forecast (2016-2021)

10.1 USA Bifidobacteria Sales, Revenue Forecast (2016-2021)

10.2 USA Bifidobacteria Sales Forecast by Type (2016-2021)

10.3 USA Bifidobacteria Sales Forecast by Application (2016-2021)

10.4 Bifidobacteria Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Bifidobacteria

Table Classification of Bifidobacteria

Figure USA Sales Market Share of Bifidobacteria by Type in 2015

Figure Dry Picture

Figure Liquid Picture

Table Application of Bifidobacteria

Figure USA Sales Market Share of Bifidobacteria by Application in 2015

Figure Food Examples

Figure Drink Examples

Figure USA Bifidobacteria Sales and Growth Rate (2011-2021)

Figure USA Bifidobacteria Revenue and Growth Rate (2011-2021)

Table USA Bifidobacteria Sales of Key Manufacturers (2015 and 2016)

Table USA Bifidobacteria Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Bifidobacteria Sales Share by Manufacturers

Figure 2016 Bifidobacteria Sales Share by Manufacturers

Table USA Bifidobacteria Revenue by Manufacturers (2015 and 2016)

Table USA Bifidobacteria Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Bifidobacteria Revenue Share by Manufacturers

Table 2016 USA Bifidobacteria Revenue Share by Manufacturers

Table USA Market Bifidobacteria Average Price of Key Manufacturers (2015 and 2016)

Figure USA Market Bifidobacteria Average Price of Key Manufacturers in 2015

Figure Bifidobacteria Market Share of Top 3 Manufacturers

Figure Bifidobacteria Market Share of Top 5 Manufacturers

Table USA Bifidobacteria Sales by Type (2011-2016)

Table USA Bifidobacteria Sales Share by Type (2011-2016)

Figure USA Bifidobacteria Sales Market Share by Type in 2015

Table USA Bifidobacteria Revenue and Market Share by Type (2011-2016)

Table USA Bifidobacteria Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Bifidobacteria by Type (2011-2016)

Table USA Bifidobacteria Price by Type (2011-2016)

Figure USA Bifidobacteria Sales Growth Rate by Type (2011-2016)

Table USA Bifidobacteria Sales by Application (2011-2016)

Table USA Bifidobacteria Sales Market Share by Application (2011-2016)

Figure USA Bifidobacteria Sales Market Share by Application in 2015

Table USA Bifidobacteria Sales Growth Rate by Application (2011-2016)

Figure USA Bifidobacteria Sales Growth Rate by Application (2011-2016)

Table Lallemand, Inc Basic Information List

Table Lallemand, Inc Bifidobacteria Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Lallemand, Inc Bifidobacteria Sales Market Share (2011-2016)

Table Koninklijke DSM N.V Basic Information List

Table Koninklijke DSM N.V Bifidobacteria Sales, Revenue, Price and Gross Margin (2011-2016)

Table Koninklijke DSM N.V Bifidobacteria Sales Market Share (2011-2016)

Table Cargill, Inc Basic Information List

Table Cargill, Inc Bifidobacteria Sales, Revenue, Price and Gross Margin (2011-2016)

Table Cargill, Inc Bifidobacteria Sales Market Share (2011-2016)

Table Chr. Hansen Holding A/S Basic Information List

Table Chr. Hansen Holding A/S Bifidobacteria Sales, Revenue, Price and Gross Margin (2011-2016)

Table Chr. Hansen Holding A/S Bifidobacteria Sales Market Share (2011-2016)

Table E.I. du Pont de Nemours and Company Basic Information List

Table E.I. du Pont de Nemours and Company Bifidobacteria Sales, Revenue, Price and Gross Margin (2011-2016)

Table E.I. du Pont de Nemours and Company Bifidobacteria Sales Market Share (2011-2016)

Table Lesaffre Group Basic Information List

Table Lesaffre Group Bifidobacteria Sales, Revenue, Price and Gross Margin (2011-2016)

Table Lesaffre Group Bifidobacteria Sales Market Share (2011-2016)

Table Novozymes Basic Information List

Table Novozymes Bifidobacteria Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novozymes Bifidobacteria Sales Market Share (2011-2016)

Table Advanced BioNutrition Corporation Basic Information List

Table Advanced BioNutrition Corporation Bifidobacteria Sales, Revenue, Price and Gross Margin (2011-2016)

Table Advanced BioNutrition Corporation Bifidobacteria Sales Market Share (2011-2016)

Table Calpis Co., Ltd Basic Information List

Table Calpis Co., Ltd Bifidobacteria Sales, Revenue, Price and Gross Margin (2011-2016)

Table Calpis Co., Ltd Bifidobacteria Sales Market Share (2011-2016)

Table Nebraska Cultures Inc Basic Information List

Table Nebraska Cultures Inc Bifidobacteria Sales, Revenue, Price and Gross Margin (2011-2016)

Table Nebraska Cultures Inc Bifidobacteria Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Bifidobacteria

Figure Manufacturing Process Analysis of Bifidobacteria

Figure Bifidobacteria Industrial Chain Analysis

Table Raw Materials Sources of Bifidobacteria Major Manufacturers in 2015

Table Major Buyers of Bifidobacteria

Table Distributors/Traders List

Figure USA Bifidobacteria Production and Growth Rate Forecast (2016-2021)

Figure USA Bifidobacteria Revenue and Growth Rate Forecast (2016-2021)

Table USA Bifidobacteria Production Forecast by Type (2016-2021)

Table USA Bifidobacteria Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390